Trade Bristol Myers ^BMY

MRA Advisory Group Buys Shares of 23,652 Bristol Myers Squibb Company $BMY

Rockland Trust Co. Has $8.47 Million Holdings in Bristol Myers Squibb Company $BMY

MRA Advisory Group Buys New Holdings in Bristol Myers Squibb Company $BMY - Stock Observer

Foresight Capital Management Advisors Inc. Purchases 11,774 Shares of Bristol Myers Squibb Company $BMY - Daily Political

CYTK Q2 Earnings Top Estimates, Myqorzo Uptake Strong

Cancer Monoclonal Antibodies Market Size & Share Analysis | Growth Trends and Forecasts (2026- 2031) | Covers Five Global Regions

Czech National Bank Purchases 26,627 Shares of Bristol Myers Squibb Company $BMY

How the FTSE became a 'departure lounge' for British companies

Replimune Wins FDA Accelerated Nod For TUDRIQEV In Advanced Melanoma

Replimune Wins FDA Accelerated Nod For TUDRIQEVTM In Advanced Melanoma

AI-based augmentation of oncology clinical trials

Bristol Myers Squibb Company (NYSE:BMY) Receives Consensus Recommendation of "Moderate Buy" from Analysts

Canandaigua National Bank & Trust Co. Takes Position in Bristol Myers Squibb Company $BMY

High-Stakes 100-Billion-Yuan Mega Investment Gamble Unfolds: What's Next for the Trillion-Scale Economic Bet?

Schrödinger (SDGR) Is Up 8.5% After AI Co‑Scientist Deal With BMS And Q2 Profitability Shift - Has The Bull Case Changed?

AstraZeneca and Bristol Myers Squibb: No Ongoing Merger Discussions Confirmed, ETPharma

Prediction: AbbVie Will End The Year at This Price

AstraZeneca and Bristol Myers Squibb merger talks denied

Exclusive-'No discussions' over AstraZeneca-Bristol Myers deal, senior source says

Analyst Report: Bristol-Myers Squibb Co

Bristol Myers Squibb (NYSE:BMY) Stock Rating Upgraded by Argus - Daily Political

Integrating clinically actionable biomarkers into bladder cancer care - recommendations from the International Bladder Cancer Group

Promising Dividend Stocks To Watch Today - August 4th - Stock Observer

Brokers split on AstraZeneca merger talk as shares recover some ground

BioNTech Q2 Earnings Call Highlights

Hilltop National Bank Invests $1.44 Million in Astrazeneca Plc $AZN

Hilltop National Bank Buys Shares of 7,577 Astrazeneca Plc $AZN - Stock Observer

Why Did AMZN, SNOW, BMY Stocks Surge To 52-Week Highs Today?

UK's AstraZeneca eyeing $400b merger, report says - World - Chinadaily.com.cn

Navigating evidence-based recommendations for the management of systemic sclerosis

European shares start August higher on US-Iran diplomacy hopes

Amazon joins US$3t market cap club as cheaper oil buoys market

The $400 Billion Reason Bristol-Myers Squibb (BMY) Stock Is Up Today

AstraZeneca Stock Plunges 7.7% on Reported $400 Billion Merger Talks

Dow Jones Top Company Headlines at 1 PM ET: Rising Beef Costs Pressure Tyson's Bottom Line | Lantheus ... | Morningstar

Top Healthcare Analyst: A $400 Billion AstraZeneca-Bristol Myers Deal Could "Cut Costs in a Big Way"

AstraZeneca-Bristol Myers Squibb merger 'is not highly likely to happen,' says UBS' Michael Yee

Astrazeneca (NYSE:AZN) Shares Gap Down - Should You Sell? - Markets Daily

AstraZeneca Slides 8% On Report Of Potential Bristol Myers Merger Talks

AstraZeneca and Bristol-Myers Squibb: Megamerger Reports Leave Us Scratching Our Heads | Morningstar

Bristol Myers Squibb (NYSE:BMY) Sets New 12-Month High After Analyst Upgrade

Bristol Myers Squibb Stock Jumps on Reported Merger Talks With AstraZeneca

Live Nasdaq Composite: Stock Market Bulls Wrestle Control to Start August as Oil Drops 6%

An AstraZeneca, Bristol Myers Squibb merger could create a cancer-drug giant, but analysts call it 'odd' | Morningstar

Astrazeneca (NYSE:AZN) Shares Gap Down - Here's Why - Stock Observer

A $400 Billion Pharma Deal Could Get Really Messy: Chris Hughes

AstraZeneca Weighs a Deal Its CEO Said It Didn't Need

Report: AstraZeneca explores tie-up with Bristol Myers Squibb

Stocks making the biggest moves premarket: BABA, BMY, EBAY & more

Dow Jones Top Company Headlines at 7 AM ET: AstraZeneca Shares Drop, Bristol Myers Squibb's Climb After Merger Talks Reports | Banco ... | Morningstar

AstraZeneca reported tie-up talks with Bristol-Myers Squibb are moving stocks. Analysts are puzzled. | Morningstar

AstraZeneca shares sink 7% on report of historic $400 billion merger talks with Bristol Myers Squibb

Morgan Stanley uncovers major Bristol Myers stock signals

North American Morning Briefing: Stock Futures Up, Oil Slumps After Trump Calls Off Iran Attack | Morningstar

Hamilton Wealth LLC Lowers Stake in Bristol Myers Squibb Company $BMY

AstraZeneca Shares Drop, Bristol Myers Squibb's Climb After Merger Talks Reports - Update | Morningstar

Bristol Myers Squibb Company $BMY Stake Lowered by Pacer Advisors Inc.

Rathbones Group PLC Has $1.56 Billion Stock Holdings in Astrazeneca Plc $AZN - Markets Daily

U.S. Stock Futures Rise, Oil Falls as U.S. Shifts Toward Diplomacy with Iran | Morningstar

| Country News

AstraZeneca Shares Drop After Reports of Bristol Myers Squibb Merger Talks | Morningstar

Bristol Myers Squibb (BMY) In Early Merger Talks With AstraZeneca

AstraZeneca shares tumble 7% after reported Bristol Myers talks

AstraZeneca shares drop 7% after report on $400 billion merger talks with Bristol Myers Squibb

AstraZeneca in talks over £300bn mega-merger with US rival - reports

AstraZeneca Held Talks to Combine With Bristol Myers Squibb, FT Says, Citing Sources | Morningstar

AstraZeneca and Bristol Myers Squibb Explore $400 Billion Merger Talks, ETPharma

AstraZeneca And Bristol Myers Reportedly In Talks On $400 Bln Deal

AstraZeneca in discussions to combine with Bristol Myers for $400B, FT says

AstraZeneca holds talks with Bristol Myers Squibb on $400 billion megadeal, FT reports

AstraZeneca and Bristol-Myers Squibb in talks over potential merger - Report

AstraZeneca plots £300bn tie-up with US rival

AstraZeneca in talks with Bristol Myers Squibb on $400 billion megadeal, FT reports

AstraZeneca, Bristol Myers Squibb Held Talks for Tie-Up, FT Says

Bristol-Myers Squibb Company Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Caerus Investment Advisors LLC Reduces Holdings in Bristol Myers Squibb Company $BMY - Zolmax

Caerus Investment Advisors LLC Decreases Stake in Bristol Myers Squibb Company $BMY - Daily Political

7,860 Shares in Bristol Myers Squibb Company $BMY Bought by Westshore Wealth LLC - Markets Daily

Westshore Wealth LLC Takes $477,000 Position in Bristol Myers Squibb Company $BMY - Zolmax

Bristol Myers Squibb Isn't Nearly as Cheap as It Looks -- Here's the 1 Thing That Could Change That

WNY Asset Management LLC Acquires Shares of 13,024 Bristol Myers Squibb Company $BMY - Zolmax

13,024 Shares in Bristol Myers Squibb Company $BMY Purchased by WNY Asset Management LLC - Markets Daily

Bristol Myers Squibb (NYSE:BMY) Given New $64.00 Price Target at Royal Bank Of Canada - Zolmax

BMY Q2 Deep Dive: Growth Portfolio and Pipeline Progress Drive Upgraded Outlook

Bristol Myers Squibb Q2 Earnings Call Highlights

Centaurus Financial Inc. Increases Position in Bristol Myers Squibb Company $BMY - Daily Political

BMY: Q2 Execution And Late Stage Pipeline Will Drive Re Rating

Bristol Myers Squibb (NYSE:BMY) Price Target Raised to $64.00

JPMorgan Chase & Co. Raises Bristol Myers Squibb (NYSE:BMY) Price Target to $73.00

Bristol Myers Squibb (NYSE:BMY) Receives "Buy" Rating from Truist Financial

FDA panel backs Replimune melanoma drug RP1 in 10-3 vote

Vestor Capital LLC Invests $10.57 Million in Bristol Myers Squibb Company $BMY

Orographic Financial Advisors LLC Buys Shares of 51,374 Bristol Myers Squibb Company $BMY - Markets Daily

Orographic Financial Advisors LLC Acquires Shares of 51,374 Bristol Myers Squibb Company $BMY - Zolmax

Bristol Myers Squibb (BMY) Earnings Beat And Higher Outlook Put Valuation Back In Focus

Bristol Myers Squibb's (BMY) "Buy" Rating Reaffirmed at Truist Financial - Daily Political